Influenza Virus Vaccine (H1N1) Market Report

Global and China Influenza Virus Vaccine (H1N1) Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 01, 2022
  • PAGES：218
  • REPORT CODE：GMM1333925
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Influenza Virus Vaccine (H1N1) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • CSL

    • Dalian Yalifeng Bio-Pharmaceutical

    • Zhejiang Tianyuan Bio-Pharmaceutical

    • Changchun Changsheng Bio-Technology

    • Sinopharm

    • Sanofi Pasteur

    • Medimmune

    • Jiangsu Yanshen Bio-Technology

    • Beijing Kexing Bio-Vaccine

    • Hualan Bio-Vaccine

    • GSK

    • NVS(Novartis)

    • Beijing Tiantan Bio-Products

    • Baxter

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Intramuscular Vaccine

    • Nasal Spray Vaccine

    Application:

    • 3 To 10 Years Old

    • 10 To 18 Years Old

    • Above 18 Years Old

    • Other

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Influenza Virus Vaccine (H1N1) Industry Overview

      • 1.1.1 Influenza Virus Vaccine (H1N1) Market Scope and Market Segments

      • 1.1.2 Influenza Virus Vaccine (H1N1) Industry Characteristics

      • 1.1.3 Global and China Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Influenza Virus Vaccine (H1N1) Production Value and Growth Rate (2017-2028)

    • 1.2 Global Influenza Virus Vaccine (H1N1) Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Intramuscular Vaccine

      • 1.2.2 Nasal Spray Vaccine

    • 1.3 Global Influenza Virus Vaccine (H1N1) Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 3 To 10 Years Old

      • 1.3.2 10 To 18 Years Old

      • 1.3.3 Above 18 Years Old

      • 1.3.4 Other

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Influenza Virus Vaccine (H1N1) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Influenza Virus Vaccine (H1N1) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Influenza Virus Vaccine (H1N1) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Influenza Virus Vaccine (H1N1) Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Influenza Virus Vaccine (H1N1) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Influenza Virus Vaccine (H1N1) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Influenza Virus Vaccine (H1N1) Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Influenza Virus Vaccine (H1N1) Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Influenza Virus Vaccine (H1N1) Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Influenza Virus Vaccine (H1N1) Industry Porter's Five Forces Model Analysis

      • 2.2.3 Influenza Virus Vaccine (H1N1) Industry PEST Analysis

    • 2.3 Influenza Virus Vaccine (H1N1) Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Influenza Virus Vaccine (H1N1) Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Influenza Virus Vaccine (H1N1) Industry

    Chapter 3 Global and China Influenza Virus Vaccine (H1N1) Market, by Manufacturer

    • 3.1 Global and China Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Influenza Virus Vaccine (H1N1) Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Influenza Virus Vaccine (H1N1) Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Influenza Virus Vaccine (H1N1) Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Influenza Virus Vaccine (H1N1) Market Top 3 Players

    Chapter 4 Global and China Influenza Virus Vaccine (H1N1) Market, by Type (2017-2028)

    • 4.1 Influenza Virus Vaccine (H1N1) Market Trend, by Type

    • 4.2 Global Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Influenza Virus Vaccine (H1N1) Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Influenza Virus Vaccine (H1N1) Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Influenza Virus Vaccine (H1N1) Price Trend, by Type (2017-2028)

    • 4.3 China Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Influenza Virus Vaccine (H1N1) Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Influenza Virus Vaccine (H1N1) Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Influenza Virus Vaccine (H1N1) Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Influenza Virus Vaccine (H1N1) Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Influenza Virus Vaccine (H1N1) Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Influenza Virus Vaccine (H1N1) Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Influenza Virus Vaccine (H1N1) Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Influenza Virus Vaccine (H1N1) Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Influenza Virus Vaccine (H1N1) Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Influenza Virus Vaccine (H1N1) Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Influenza Virus Vaccine (H1N1) Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Influenza Virus Vaccine (H1N1) Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Influenza Virus Vaccine (H1N1) Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Influenza Virus Vaccine (H1N1) Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Influenza Virus Vaccine (H1N1) Market Analysis

    • 7.1 North America Influenza Virus Vaccine (H1N1) Market, by Type

    • 7.2 North America Influenza Virus Vaccine (H1N1) Market, by Application

    • 7.3 North America Influenza Virus Vaccine (H1N1) Market Analysis and Forecast, by Country

      • 7.3.1 United States Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Influenza Virus Vaccine (H1N1) Market Analysis

    • 8.1 Europe Influenza Virus Vaccine (H1N1) Market, by Type

    • 8.2 Europe Influenza Virus Vaccine (H1N1) Market, by Application

    • 8.3 Europe Influenza Virus Vaccine (H1N1) Market Analysis and Forecast, by Country

      • 8.3.1 Germany Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Influenza Virus Vaccine (H1N1) Market Analysis

    • 9.1 APAC Influenza Virus Vaccine (H1N1) Market, by Type

    • 9.2 APAC Influenza Virus Vaccine (H1N1) Market, by Application

    • 9.3 APAC Influenza Virus Vaccine (H1N1) Market Analysis and Forecast, by Country

      • 9.3.1 China Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Influenza Virus Vaccine (H1N1) Market Analysis

    • 10.1 Latin America, Middle East and Africa Influenza Virus Vaccine (H1N1) Market, by Type

    • 10.2 Latin America, Middle East and Africa Influenza Virus Vaccine (H1N1) Market, by Application

    • 10.3 Latin America, Middle East and Africa Influenza Virus Vaccine (H1N1) Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Influenza Virus Vaccine (H1N1) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Influenza Virus Vaccine (H1N1) Company Profiles

      • 11.1 CSL

        • 11.1.1 CSL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 CSL Influenza Virus Vaccine (H1N1) Product Profiles, Application and Specification

        • 11.1.3 CSL Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Dalian Yalifeng Bio-Pharmaceutical

        • 11.2.1 Dalian Yalifeng Bio-Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Profiles, Application and Specification

        • 11.2.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Zhejiang Tianyuan Bio-Pharmaceutical

        • 11.3.1 Zhejiang Tianyuan Bio-Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Profiles, Application and Specification

        • 11.3.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Changchun Changsheng Bio-Technology

        • 11.4.1 Changchun Changsheng Bio-Technology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Profiles, Application and Specification

        • 11.4.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Sinopharm

        • 11.5.1 Sinopharm Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Sinopharm Influenza Virus Vaccine (H1N1) Product Profiles, Application and Specification

        • 11.5.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Sanofi Pasteur

        • 11.6.1 Sanofi Pasteur Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Profiles, Application and Specification

        • 11.6.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Medimmune

        • 11.7.1 Medimmune Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Medimmune Influenza Virus Vaccine (H1N1) Product Profiles, Application and Specification

        • 11.7.3 Medimmune Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Jiangsu Yanshen Bio-Technology

        • 11.8.1 Jiangsu Yanshen Bio-Technology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Profiles, Application and Specification

        • 11.8.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Beijing Kexing Bio-Vaccine

        • 11.9.1 Beijing Kexing Bio-Vaccine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Profiles, Application and Specification

        • 11.9.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Hualan Bio-Vaccine

        • 11.10.1 Hualan Bio-Vaccine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Profiles, Application and Specification

        • 11.10.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 GSK

        • 11.11.1 GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 GSK Influenza Virus Vaccine (H1N1) Product Profiles, Application and Specification

        • 11.11.3 GSK Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 NVS(Novartis)

        • 11.12.1 NVS(Novartis) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Profiles, Application and Specification

        • 11.12.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Beijing Tiantan Bio-Products

        • 11.13.1 Beijing Tiantan Bio-Products Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Profiles, Application and Specification

        • 11.13.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Baxter

        • 11.14.1 Baxter Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Baxter Influenza Virus Vaccine (H1N1) Product Profiles, Application and Specification

        • 11.14.3 Baxter Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Influenza Virus Vaccine (H1N1) Industry Investment Prospect and Risk Assessment

    • 12.1 Influenza Virus Vaccine (H1N1) Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Influenza Virus Vaccine (H1N1) Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure China Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure Global Influenza Virus Vaccine (H1N1) Production Value and Growth Rate (2017-2028)

    • Figure China Influenza Virus Vaccine (H1N1) Production Value and Growth Rate (2017-2028)

    • Figure Global Influenza Virus Vaccine (H1N1) Market Size and Growth Rate of Intramuscular Vaccine (2017-2028)

    • Figure Global Influenza Virus Vaccine (H1N1) Market Size and Growth Rate of Nasal Spray Vaccine (2017-2028)

    • Figure Global Influenza Virus Vaccine (H1N1) Market Size and Growth Rate of 3 To 10 Years Old (2017-2028)

    • Figure Global Influenza Virus Vaccine (H1N1) Market Size and Growth Rate of 10 To 18 Years Old (2017-2028)

    • Figure Global Influenza Virus Vaccine (H1N1) Market Size and Growth Rate of Above 18 Years Old (2017-2028)

    • Figure Global Influenza Virus Vaccine (H1N1) Market Size and Growth Rate of Other (2017-2028)

    • Figure North America Influenza Virus Vaccine (H1N1) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Influenza Virus Vaccine (H1N1) Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Influenza Virus Vaccine (H1N1) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Influenza Virus Vaccine (H1N1) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Influenza Virus Vaccine (H1N1) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Influenza Virus Vaccine (H1N1) Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Influenza Virus Vaccine (H1N1) Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Influenza Virus Vaccine (H1N1) Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Influenza Virus Vaccine (H1N1) Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Influenza Virus Vaccine (H1N1) Market Share, by Manufacturer in 2021

    • Figure Global and China Influenza Virus Vaccine (H1N1) Market Share, by Manufacturer in 2022

    • Table Global Influenza Virus Vaccine (H1N1) Sales Volume, by Type (2017-2028)

    • Table Global Influenza Virus Vaccine (H1N1) Sales Volume Share, by Type (2017-2028)

    • Figure Global Influenza Virus Vaccine (H1N1) Sales Volume Share, by Type (2017-2028)

    • Table Global Influenza Virus Vaccine (H1N1) Sales Value, by Type (2017-2028)

    • Table Global Influenza Virus Vaccine (H1N1) Sales Value Share, by Type (2017-2028)

    • Figure Global Influenza Virus Vaccine (H1N1) Price Trend, by Type (2017-2028)

    • Table China Influenza Virus Vaccine (H1N1) Sales Volume, by Type (2017-2028)

    • Table China Influenza Virus Vaccine (H1N1) Sales Volume Share, by Type (2017-2028)

    • Figure China Influenza Virus Vaccine (H1N1) Sales Volume Share, by Type (2017-2028)

    • Table China Influenza Virus Vaccine (H1N1) Sales Value, by Type (2017-2028)

    • Table China Influenza Virus Vaccine (H1N1) Sales Value Share, by Type (2017-2028)

    • Figure China Influenza Virus Vaccine (H1N1) Price Trend, by Type (2017-2028)

    • Table Global Influenza Virus Vaccine (H1N1) Sales Volume, by Application (2017-2028)

    • Table Global Influenza Virus Vaccine (H1N1) Sales Volume Share, by Application (2017-2028)

    • Figure Global Influenza Virus Vaccine (H1N1) Sales Volume Share, by Application (2017-2028)

    • Table Global Influenza Virus Vaccine (H1N1) Sales Value, by Application (2017-2028)

    • Table Global Influenza Virus Vaccine (H1N1) Sales Value Share, by Application (2017-2028)

    • Figure Global Influenza Virus Vaccine (H1N1) Sales Value Share, by Application (2017-2028)

    • Table China Influenza Virus Vaccine (H1N1) Sales Volume, by Application (2017-2028)

    • Table China Influenza Virus Vaccine (H1N1) Sales Volume Share, by Application (2017-2028)

    • Figure China Influenza Virus Vaccine (H1N1) Sales Volume Share, by Application (2017-2028)

    • Table China Influenza Virus Vaccine (H1N1) Sales Value, by Application (2017-2028)

    • Table China Influenza Virus Vaccine (H1N1) Sales Value Share, by Application (2017-2028)

    • Figure China Influenza Virus Vaccine (H1N1) Sales Value Share, by Application (2017-2028)

    • Figure China Influenza Virus Vaccine (H1N1) Production, Import, Consumption and Export (2017-2022)

    • Figure North America Influenza Virus Vaccine (H1N1) Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Influenza Virus Vaccine (H1N1) Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Influenza Virus Vaccine (H1N1) Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Influenza Virus Vaccine (H1N1) Production, Import, Consumption and Export (2017-2022)

    • Table North America Influenza Virus Vaccine (H1N1) Sales Volume, by Type (2017-2028)

    • Table North America Influenza Virus Vaccine (H1N1) Sales Volume Share, by Type (2017-2028)

    • Figure North America Influenza Virus Vaccine (H1N1) Sales Volume Share, by Type (2017-2028)

    • Table North America Influenza Virus Vaccine (H1N1) Sales Volume, by Application (2017-2028)

    • Table North America Influenza Virus Vaccine (H1N1) Sales Volume Share, by Application (2017-2028)

    • Figure North America Influenza Virus Vaccine (H1N1) Sales Volume Share, by Application (2017-2028)

    • Figure United States Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure United States Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Figure Canada Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Table Europe Influenza Virus Vaccine (H1N1) Sales Volume, by Type (2017-2028)

    • Table Europe Influenza Virus Vaccine (H1N1) Sales Volume Share, by Type (2017-2028)

    • Figure Europe Influenza Virus Vaccine (H1N1) Sales Volume Share, by Type (2017-2028)

    • Table Europe Influenza Virus Vaccine (H1N1) Sales Volume, by Application (2017-2028)

    • Table Europe Influenza Virus Vaccine (H1N1) Sales Volume Share, by Application (2017-2028)

    • Figure Europe Influenza Virus Vaccine (H1N1) Sales Volume Share, by Application (2017-2028)

    • Figure Germany Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Figure UK Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure UK Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Figure France Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure France Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Figure Italy Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Figure Spain Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Figure Poland Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Figure Russia Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Table APAC Influenza Virus Vaccine (H1N1) Sales Volume, by Type (2017-2028)

    • Table APAC Influenza Virus Vaccine (H1N1) Sales Volume Share, by Type (2017-2028)

    • Figure APAC Influenza Virus Vaccine (H1N1) Sales Volume Share, by Type (2017-2028)

    • Table APAC Influenza Virus Vaccine (H1N1) Sales Volume, by Application (2017-2028)

    • Table APAC Influenza Virus Vaccine (H1N1) Sales Volume Share, by Application (2017-2028)

    • Figure APAC Influenza Virus Vaccine (H1N1) Sales Volume Share, by Application (2017-2028)

    • Figure China Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure China Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Figure Japan Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Figure India Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure India Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Influenza Virus Vaccine (H1N1) Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Influenza Virus Vaccine (H1N1) Sales Value and Growth Rate (2017-2028)

    • Table CSL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CSL Product Profiles, Application and Specification

    • Table CSL Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Dalian Yalifeng Bio-Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Dalian Yalifeng Bio-Pharmaceutical Product Profiles, Application and Specification

    • Table Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Zhejiang Tianyuan Bio-Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Zhejiang Tianyuan Bio-Pharmaceutical Product Profiles, Application and Specification

    • Table Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Changchun Changsheng Bio-Technology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Changchun Changsheng Bio-Technology Product Profiles, Application and Specification

    • Table Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sinopharm Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sinopharm Product Profiles, Application and Specification

    • Table Sinopharm Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Pasteur Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Pasteur Product Profiles, Application and Specification

    • Table Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Medimmune Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Medimmune Product Profiles, Application and Specification

    • Table Medimmune Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Jiangsu Yanshen Bio-Technology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Jiangsu Yanshen Bio-Technology Product Profiles, Application and Specification

    • Table Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Beijing Kexing Bio-Vaccine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Beijing Kexing Bio-Vaccine Product Profiles, Application and Specification

    • Table Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hualan Bio-Vaccine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hualan Bio-Vaccine Product Profiles, Application and Specification

    • Table Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GSK Product Profiles, Application and Specification

    • Table GSK Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table NVS(Novartis) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table NVS(Novartis) Product Profiles, Application and Specification

    • Table NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Beijing Tiantan Bio-Products Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Beijing Tiantan Bio-Products Product Profiles, Application and Specification

    • Table Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Baxter Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Baxter Product Profiles, Application and Specification

    • Table Baxter Influenza Virus Vaccine (H1N1) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US